vs
Side-by-side financial comparison of ARGENX SE (ARGX) and PILGRIMS PRIDE CORP (PPC). Click either name above to swap in a different company.
PILGRIMS PRIDE CORP is the larger business by last-quarter revenue ($4.5B vs $2.5B, roughly 1.8× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs 2.2%, a 33.2% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 1.6%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Pilgrim's Pride Corporation is an American, multi-national food company, currently one of the largest chicken producers in the United States and Puerto Rico and the second-largest chicken producer in Mexico. It exited bankruptcy in December 2009 and relocated its U.S. headquarters to Greeley, Colorado, in 2011. It is majority-owned by JBS S.A. Pilgrim's Pride purchased Gold'n Plump for $350 million in late November 2016.
ARGX vs PPC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $2.5B | $4.5B |
| Net Profit | $877.2M | $101.5M |
| Gross Margin | 89.5% | 7.6% |
| Operating Margin | 28.9% | 3.6% |
| Net Margin | 35.5% | 2.2% |
| Revenue YoY | 83.2% | 1.6% |
| Net Profit YoY | 1.3% | — |
| EPS (diluted) | $13.25 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $4.5B | ||
| Q4 25 | $2.5B | $4.5B | ||
| Q3 25 | — | $4.8B | ||
| Q2 25 | $1.8B | $4.8B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | $1.4B | $4.4B | ||
| Q3 24 | — | $4.6B | ||
| Q2 24 | $901.9M | $4.6B |
| Q1 26 | — | $101.5M | ||
| Q4 25 | $877.2M | $88.0M | ||
| Q3 25 | — | $342.8M | ||
| Q2 25 | $414.8M | $355.5M | ||
| Q1 25 | — | $296.0M | ||
| Q4 24 | $865.6M | $235.9M | ||
| Q3 24 | — | $349.9M | ||
| Q2 24 | $-32.5M | $326.3M |
| Q1 26 | — | 7.6% | ||
| Q4 25 | 89.5% | 9.5% | ||
| Q3 25 | — | 13.9% | ||
| Q2 25 | 89.2% | 15.0% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | 90.2% | 12.7% | ||
| Q3 24 | — | 14.9% | ||
| Q2 24 | 89.4% | 15.2% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | 28.9% | 4.5% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | 19.2% | 10.8% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | 8.7% | 7.0% | ||
| Q3 24 | — | 11.1% | ||
| Q2 24 | -15.4% | 9.7% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 35.5% | 1.9% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | 23.4% | 7.5% | ||
| Q1 25 | — | 6.6% | ||
| Q4 24 | 64.1% | 5.4% | ||
| Q3 24 | — | 7.6% | ||
| Q2 24 | -3.6% | 7.2% |
| Q1 26 | — | $0.43 | ||
| Q4 25 | $13.25 | $0.37 | ||
| Q3 25 | — | $1.44 | ||
| Q2 25 | $6.32 | $1.49 | ||
| Q1 25 | — | $1.24 | ||
| Q4 24 | $13.33 | $1.00 | ||
| Q3 24 | — | $1.47 | ||
| Q2 24 | $-0.55 | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $542.4M |
| Total DebtLower is stronger | — | $3.1B |
| Stockholders' EquityBook value | $7.3B | $3.7B |
| Total Assets | $8.7B | $10.2B |
| Debt / EquityLower = less leverage | — | 0.83× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $542.4M | ||
| Q4 25 | $3.5B | $640.2M | ||
| Q3 25 | — | $612.6M | ||
| Q2 25 | $2.1B | $849.0M | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | $1.4B | $1.3B |
| Q1 26 | — | $3.1B | ||
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $3.2B | ||
| Q4 24 | — | $3.2B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | $11.0M | $3.2B |
| Q1 26 | — | $3.7B | ||
| Q4 25 | $7.3B | $3.7B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | $6.1B | $3.7B | ||
| Q1 25 | — | $3.1B | ||
| Q4 24 | $5.5B | $4.2B | ||
| Q3 24 | — | $4.2B | ||
| Q2 24 | $4.3B | $3.7B |
| Q1 26 | — | $10.2B | ||
| Q4 25 | $8.7B | $10.3B | ||
| Q3 25 | — | $10.0B | ||
| Q2 25 | $7.2B | $10.1B | ||
| Q1 25 | — | $11.0B | ||
| Q4 24 | $6.2B | $10.7B | ||
| Q3 24 | — | $10.7B | ||
| Q2 24 | $4.8B | $10.1B |
| Q1 26 | — | 0.83× | ||
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.87× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 1.02× | ||
| Q4 24 | — | 0.76× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | 0.00× | 0.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | — |
| Free Cash FlowOCF − Capex | $322.4M | — |
| FCF MarginFCF / Revenue | 13.0% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 0.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $323.3M | $291.2M | ||
| Q3 25 | — | $458.3M | ||
| Q2 25 | $361.8M | $495.2M | ||
| Q1 25 | — | $126.9M | ||
| Q4 24 | $41.9M | $349.3M | ||
| Q3 24 | — | $651.1M | ||
| Q2 24 | $-124.7M | $718.6M |
| Q1 26 | — | — | ||
| Q4 25 | $322.4M | $10.0M | ||
| Q3 25 | — | $275.9M | ||
| Q2 25 | $356.6M | $339.1M | ||
| Q1 25 | — | $28.1M | ||
| Q4 24 | $40.9M | $176.6M | ||
| Q3 24 | — | $565.3M | ||
| Q2 24 | $-125.5M | $617.7M |
| Q1 26 | — | — | ||
| Q4 25 | 13.0% | 0.2% | ||
| Q3 25 | — | 5.8% | ||
| Q2 25 | 20.1% | 7.1% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 3.0% | 4.0% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | -13.9% | 13.5% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 6.2% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | 0.3% | 3.3% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | 0.1% | 4.0% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | 0.1% | 2.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | 3.31× | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | 0.87× | 1.39× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | 0.05× | 1.48× | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | — | 2.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARGX
Segment breakdown not available.
PPC
| U.S | $2.6B | 58% |
| Europe | $1.4B | 30% |
| Mexico | $545.5M | 12% |